Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1187594-14-4
2. Ilunocitinib [usan]
3. Ly3411067
4. N3tb5ah8b9
5. Ly-3411067
6. 2-[1-cyclopropylsulfonyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile
7. Ilunocitinib [inn]
8. 3-azetidineacetonitrile, 1-(cyclopropylsulfonyl)-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)-
9. 1-(cyclopropylsulfonyl)-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-azetidineacetonitrile
10. 2-(1-cyclopropylsulfonyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)azetidin-3-yl)acetonitrile
11. Refchem:147900
12. Unii-n3tb5ah8b9
13. Who 11894
14. (1-(cyclopropanesulfonyl)-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)azetidin-3-yl)acetonitrile
15. 2-(3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile
16. Schembl870650
17. Orb2704076
18. Orb2944228
19. Chembl4802241
20. Schembl29577031
21. Gtpl11670
22. Rvouexfkiynodq-uhfffaoysa-n
23. Ex-a9647
24. Akos040756527
25. Da-74442
26. Ms-26294
27. Hy-132819
28. Cs-0204093
29. G18507
30. (1-(cyclopropylsulfonyl)-3-(4-(1,5,7-triaza-1h-inden-4-yl)-1-pyrazolyl)-3-azetidinyl)acetonitrile
| Molecular Weight | 383.4 g/mol |
|---|---|
| Molecular Formula | C17H17N7O2S |
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 129 |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 734 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
75
PharmaCompass offers a list of Ilunocitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ilunocitinib manufacturer or Ilunocitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ilunocitinib manufacturer or Ilunocitinib supplier.
A Ilunocitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ilunocitinib, including repackagers and relabelers. The FDA regulates Ilunocitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ilunocitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ilunocitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Ilunocitinib supplier is an individual or a company that provides Ilunocitinib active pharmaceutical ingredient (API) or Ilunocitinib finished formulations upon request. The Ilunocitinib suppliers may include Ilunocitinib API manufacturers, exporters, distributors and traders.
click here to find a list of Ilunocitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
Ilunocitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ilunocitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ilunocitinib GMP manufacturer or Ilunocitinib GMP API supplier for your needs.
A Ilunocitinib CoA (Certificate of Analysis) is a formal document that attests to Ilunocitinib's compliance with Ilunocitinib specifications and serves as a tool for batch-level quality control.
Ilunocitinib CoA mostly includes findings from lab analyses of a specific batch. For each Ilunocitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ilunocitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Ilunocitinib EP), Ilunocitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ilunocitinib USP).
